Overview

Study of ST-100 as Treatment for Dry Eye Disease

Status:
Completed

Trial end date:
2021-10-11

Target enrollment:

Participant gender:

Summary

The objective of this study is to compare the safety and efficacy of two different concentrations of ST-100 Ophthalmic Solution to placebo (vehicle) for the treatment of the signs and symptoms of dry eye.

Phase:

Phase 2

Details

Lead Sponsor:

Stuart Therapeutics, Inc.

Collaborator:

ORA, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions